BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12407766)

  • 1. Preparation of retroviral vectors for cell-cycle-targeted gene therapy of lung cancer.
    Claudio PP; Giordano A
    Methods Mol Med; 2003; 75():591-605. PubMed ID: 12407766
    [No Abstract]   [Full Text] [Related]  

  • 2. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Falkner FG
    Methods Mol Med; 2003; 76():565-78. PubMed ID: 12526185
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus.
    Carbone DP; Minna JD
    J Natl Cancer Inst; 1994 Oct; 86(19):1437-8. PubMed ID: 8089857
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying obstacles to viral gene therapy for lung cancer. Malignant pleural effusions as a paradigm.
    Batra RK; Bernal RM; Sharma S
    Methods Mol Med; 2003; 75():545-59. PubMed ID: 12407763
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudotyped retroviral vectors for studies of human gene therapy.
    Friedmann T; Yee JK
    Nat Med; 1995 Mar; 1(3):275-7. PubMed ID: 7585046
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a double-copy bicistronic retroviral vector for human gene therapy.
    Wiznerowicz M; Fong AZ; Hawley RG; Mackiewicz A
    Adv Exp Med Biol; 1998; 451():441-7. PubMed ID: 10026909
    [No Abstract]   [Full Text] [Related]  

  • 7. Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors.
    Batra RK; Olsen JC; Pickles RJ; Hoganson DK; Boucher RC
    Am J Respir Cell Mol Biol; 1998 Mar; 18(3):402-10. PubMed ID: 9490658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated gene transfer into salivary glands in vivo.
    Barka T; Van der Noen HM
    Hum Gene Ther; 1996 Mar; 7(5):613-8. PubMed ID: 8845386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral transfer of the nlsLacZ gene into human CD34+ cell populations and into TF-1 cells: future prospects in gene therapy.
    Bagnis C; Gravis G; Imbert AM; Herrera D; Allario T; Galindo R; Lopez M; Pavon C; Sempere C; Mannoni P
    Hum Gene Ther; 1994 Nov; 5(11):1325-33. PubMed ID: 7534481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using RT-prone recombination to promote re-building of complete retroviral vectors from two defective precursors: low efficiency and sequence specificities.
    Bru T; Galetto R; Piver E; Collin C; Negroni M; Pagès JC
    J Virol Methods; 2007 Jun; 142(1-2):118-26. PubMed ID: 17336399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of retroviral vectors as safe, targeted gene delivery systems.
    Günzburg WH; Salmons B
    J Mol Med (Berl); 1996 Apr; 74(4):171-82. PubMed ID: 8740648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress with retroviral gene vectors.
    Palù G; Parolin C; Takeuchi Y; Pizzato M
    Rev Med Virol; 2000; 10(3):185-202. PubMed ID: 10815029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to retroviruses and retroviral vectors.
    Buchschacher GL
    Somat Cell Mol Genet; 2001 Nov; 26(1-6):1-11. PubMed ID: 12465459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vectors.
    Kurian KM; Watson CJ; Wyllie AH
    Mol Pathol; 2000 Aug; 53(4):173-6. PubMed ID: 11040938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral gene transfer into cord blood stem/progenitor cells using purified vector stocks.
    Asch J; Weinberg RS; Mueller L; Galperin Y; Kiang L; Jolly D; Isola LM
    Am J Hematol; 1998 Jan; 57(1):16-23. PubMed ID: 9423811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo.
    Logg CR; Kasahara N
    Methods Mol Biol; 2004; 246():499-525. PubMed ID: 14970613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.
    Yee JK; Miyanohara A; LaPorte P; Bouic K; Burns JC; Friedmann T
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9564-8. PubMed ID: 7937806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection.
    Movassagh M; Boyer O; Burland MC; Leclercq V; Klatzmann D; Lemoine FM
    Hum Gene Ther; 2000 May; 11(8):1189-200. PubMed ID: 10834620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of a high-titer retroviral vector for gene transfer into skeletal myoblasts.
    el Oakley RM; Brand NJ; Burton PB; McMullen MC; Adams GB; Poznansky MC; Barton PJ; Yacoub MH
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):1-8. PubMed ID: 9451039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo.
    Kitten O; Cosset FL; Ferry N
    Hum Gene Ther; 1997 Aug; 8(12):1491-4. PubMed ID: 9287149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.